The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Brupro for Children 100 mg/5 ml oral suspension

Rowa Pharmaceuticals LimitedPA0074/067/004

Main Information

Trade NameBrupro for Children 100 mg/5 ml oral suspension
Active SubstancesIbuprofen
Dosage FormOral suspension
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/067/004

Group Information

ATC CodeM01AE01 ibuprofen


License statusAuthorised
Licence Issued11/03/2022
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back